Article
Targeting protein-trafficking pathways alters melanoma treatment sensitivity.
Proceedings of the National Academy of Sciences of the United States of America - 10 Jan 2012
Huang Zhi-ming, Chinen Milka, Chang Philip J, Xie Tong, Zhong Lily, Demetriou Stephanie, Patel Mira P, Scherzer Rebecca, Sviderskaya Elena V, Bennett Dorothy C, Millhauser Glenn L, Oh Dennis H, Cleaver James E, Wei Maria L
Abstract excerpt
Protein-trafficking pathways are targeted here in human melanoma cells using methods independent of oncogene mutational status, and the ability to up-regulate and down-regulate tumor treatment sensitivity is demonstrated. Sensitivity of melanoma cells to cis-diaminedichloroplatinum II (cDDP, cis-platin), carboplatin, dacarbazine, or temozolomide together with velaparib, an inhibitor of poly (ADP ribose)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
